Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset.
about
Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP)Henoch-Schönlein purpura in children: limited benefit of corticosteroids.The Optimal Cut-Off Value of Neutrophil-to-Lymphocyte Ratio for Predicting Prognosis in Adult Patients with Henoch-Schönlein Purpura.Henoch-Schonlein Purpura in Children Hospitalized at a Tertiary Hospital during 2004-2015 in Korea: Epidemiology and Clinical Management.The Relationship of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Gastrointestinal Bleeding in Henoch-Schonlein Purpura.Prevention of nephritis in Henoch-Schönlein purpura.Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature.Treatment of Henoch Schonlein nephritis; new trends.Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP).Establishing hospital admission criteria of pediatric Henoch-Schonlein purpura.Prevention of renal disease in Henoch-Schonlein purpura: clear evidence against steroids.The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch-Schonlein purpura.Even mild cases of paediatric Henoch-Schönlein purpura nephritis show significant long-term proteinuria.HLA-DRB1 gene polymorphisms in Iranian children with Henoch-Schönlein purpura.
P2860
Q24187962-A57E4804-7CBC-43AD-8555-21921A492123Q34497598-1D72C6CD-7441-4841-A1FC-FDBB16172B91Q35988230-C5C6011E-98B9-4DA9-B389-6F8A930B2885Q37334762-0F9CF0EC-532C-4C54-B61A-26D662F0A712Q37631281-803F09E4-5DF0-4205-A665-CB6ABC7583C3Q38353909-28106CEA-ECD8-453F-AF0E-2F038E467EA7Q38905969-805F5A81-AA32-456D-B07F-9A5826B73230Q42363000-11C909B8-9F0F-49FF-864D-AB85D1A4631AQ44821776-184CC39C-E2B6-4466-A73E-BB6ECF56480BQ44979637-38898900-DFDD-48FA-842C-CBE81848BE54Q46711370-8F1DEC02-9B21-40F7-A1A9-4031B40C5A7EQ53061532-89C23049-0D97-44B1-8AC9-53F15F98FE78Q53088190-570F6C92-9F09-4306-A2C3-84B3D931EE36Q55362548-20F04924-5A92-4130-B06F-6CE6E6325A0F
P2860
Outcome of Henoch-Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Outcome of Henoch-Schönlein pu ...... r prednisone at disease onset.
@en
Outcome of Henoch-Schönlein pu ...... r prednisone at disease onset.
@nl
type
label
Outcome of Henoch-Schönlein pu ...... r prednisone at disease onset.
@en
Outcome of Henoch-Schönlein pu ...... r prednisone at disease onset.
@nl
prefLabel
Outcome of Henoch-Schönlein pu ...... r prednisone at disease onset.
@en
Outcome of Henoch-Schönlein pu ...... r prednisone at disease onset.
@nl
P2093
P2860
P1433
P1476
Outcome of Henoch-Schönlein pu ...... r prednisone at disease onset.
@en
P2093
Jaana Ronkainen
Jukka Rajantie
Marja Ala-Houhala
Matti Nuutinen
Olli Koskimies
Outi Jauhola
Pekka Arikoski
Timo Jahnukainen
Timo Örmälä
Tuula Hölttä
P2860
P2888
P304
P356
10.1007/S00467-012-2106-Z
P577
2012-02-05T00:00:00Z